Chester County News and Community Website
WILMINGTON, DE — Incyte Corporation (Nasdaq: INCY) announced equity inducement award grants to Bill Meury following his recent appointment as the Company’s new President and CEO. The awards were granted …
Incyte Announces Equity Awards for New CEO Bill Meury with Performance-Based Incentives Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced that its Board of Directors Compensation Committee approved an inducement grant for Jim Hagen, Senior Vice President – Strategic Commercial Operations. …
TELA Bio Welcomes Jim Hagen with Strategic Equity Grant Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has granted performance restricted stock units (PRSUs) to Bill Leonard as part of an inducement award tied to his employment with the company. The …
Neuronetics Awards Stock Units to New Employee Bill Leonard Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced a significant stock option grant to David Zawitz, the company’s newly appointed Chief Operating Officer. The Compensation Committee approved a …
Verrica Pharmaceuticals Grants Stock Option to New COO David Zawitz Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has granted stock options and restricted stock units (RSUs) to multiple new employees, including its recently appointed President and Chief Operating Officer, …
Aclaris Therapeutics Announces New Employee Stock Grants Under 2024 Inducement Plan Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the approval of inducement awards to Braden Parker, who recently joined the company as Chief Commercial Officer on September 24, 2024. These …
Savara Inc. Grants Inducement Awards to New Chief Commercial Officer Read More
PLYMOUTH MEETING, PA — AdaptHealth Corp. (NASDAQ: AHCO) has announced the granting of restricted stock units (RSUs) to Suzanne Foster, the company’s newly appointed Chief Executive Officer. The RSUs cover …
AdaptHealth Grants Stock Units to New CEO Suzanne Foster Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) announced the appointment of Nadeem Q. Mirza, M.D., M.P.H., as its new Chief Medical Officer (CMO), effective May 1, 2024. Dr. Mirza, …
Aprea Therapeutics Welcomes New Chief Medical Officer to Spearhead Clinical Pipeline Expansion Read More
PHILADELPHIA, PA — On Thursday, in a virtual gathering for its 69th Annual Meeting, Enviri Corporation (NYSE: NVRI) stockholders cast their votes in favor of significant company proposals.
Enviri Corporation Stockholders Approve Key Resolutions at Annual Meeting Read More